phenoxybenzamine has been researched along with Hypokalemia in 2 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Hypokalemia: Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lambotte, L | 1 |
Wilson, RJ | 1 |
Craig, GM | 1 |
Mills, IH | 1 |
2 other studies available for phenoxybenzamine and Hypokalemia
Article | Year |
---|---|
[The role of the liver in post-insulin hypokalemia].
Topics: Animals; Dogs; Epinephrine; Hepatic Veins; Hypokalemia; Insulin; Liver; Liver Circulation; Phenoxybe | 1965 |
Metabolic studies in a patient with a phaeochromocytoma associated with hypokalaemia and hyperaldosteronism.
Topics: Adrenal Gland Neoplasms; Aldosterone; Blood Pressure; Blood Urea Nitrogen; Blood Volume; Creatinine; | 1973 |